Danai Dima, MD

Dr. Dima is a physician-researcher specializing in plasma cell disorders, including multiple myeloma, light chain amyloidosis, POEMS syndrome, smoldering myeloma, and monoclonal gammopathy of undetermined significance. She sees patients at the South Lake Union Clinic and is fluent in both English and Greek.

Dr. Dima earned her medical degree from the National and Kapodistrian University of Athens. She completed her residency in internal medicine at Tufts Medical Center and a fellowship in hematology and medical oncology at the Cleveland Clinic. She is board certified in internal medicine by the American Board of Internal Medicine (2021).

Her clinical expertise is complemented by a robust research portfolio focused on treatment outcomes in multiple myeloma, particularly involving chimeric antigen receptor T-cell therapy and bispecific antibodies. A member of the U.S. Multiple Myeloma Immunotherapy Consortium, she has authored more than 50 peer-reviewed publications.